Abstract
IgG4-related disease (IgG-RD) describes a group of fibroinflammatory diseases that affect a variety of tissues resulting in tumor-like effect and/or organ dysfunction. Clinical presentation varies according to the tissue(s) involved, and diagnosis relies on tissue findings of dense infiltration of IgG4-positive plasma cells and a characteristic storiform fibrosis. Treatment is mainly with glucocorticoids, while multiple immunosuppressive medications can be used as adjuvant agents. Rituximab has showed promising results, but further studies are needed.
Original language | English (US) |
---|---|
Pages (from-to) | 253-256 |
Number of pages | 4 |
Journal | Missouri medicine |
Volume | 115 |
Issue number | 3 |
State | Published - May 1 2018 |
ASJC Scopus subject areas
- General Medicine